Difference between revisions of "PCCTech Minutes 2015 02 23"
Jump to navigation
Jump to search
| Line 1: | Line 1: | ||
| − | ==Monday | + | ==Monday 2015 02 23 thru Thursday 02 27== |
==Attendees== | ==Attendees== | ||
* Keith Boone | * Keith Boone | ||
| Line 21: | Line 21: | ||
===RECON on FHIR=== | ===RECON on FHIR=== | ||
| − | * George led | + | * George/Emma led discussions, reviewed several sections, made some changes to document |
| − | * may need interaction with IHE-HL7 Joint Workgroup, in relation to using the provenance FHIR resource | + | * may need interaction with IHE-HL7 Joint Workgroup (HSI), in relation to using the provenance FHIR resource. Need a PSS work item for HSI with PCC and Patient Care as co-sponsors. HSI will sponsor |
* discussion around using PCC-1 Share Content | * discussion around using PCC-1 Share Content | ||
** will likely need a new transaction that provides more explicit/specific guidance | ** will likely need a new transaction that provides more explicit/specific guidance | ||
| + | * Options section need to be implementation agnostic (remove specific references to CDA, PCC TF and FHIR) | ||
===Remote Patient Monitoring (RPM)=== | ===Remote Patient Monitoring (RPM)=== | ||
* Brian led discussion, reviewed actor/transaction diagrams | * Brian led discussion, reviewed actor/transaction diagrams | ||
* discussion resulted in clarity of actor/transaction definitions, and use of grouping | * discussion resulted in clarity of actor/transaction definitions, and use of grouping | ||
| + | * Clean up of various diagrams | ||
| + | * Clean up of Other dependencies section | ||
===Device Clinical Bridge (DCB)=== | ===Device Clinical Bridge (DCB)=== | ||
| Line 34: | Line 37: | ||
* actors and transactions we reworked based on committee feedback | * actors and transactions we reworked based on committee feedback | ||
* '''next action:''' Alex to apply changes to DCM document for follow up session | * '''next action:''' Alex to apply changes to DCM document for follow up session | ||
| + | ** - updated 2nd use case - clinical to billing use case. | ||
| + | ** Clarification of Transaction (multiple back and forth until it is done - multiple activities can occur. Will be a complete business request) | ||
===Workflow Discussion=== | ===Workflow Discussion=== | ||
Revision as of 08:41, 24 February 2015
Monday 2015 02 23 thru Thursday 02 27
Attendees
- Keith Boone
- Alex Lippitt
- Isabelle G
- George Cole
- Mike Bohl
- Tone Southerland
- Thom Kuhn
- Chris Lindop
- Brian Reinhold
- Dave Stumpf
- Emma Jones
- On phone - Dragon,
Minutes
Intro/Agenda Review
- Request to record and make available the DCB discussions for those unable to attend the sessions due to time zone differences
RECON on FHIR
- George/Emma led discussions, reviewed several sections, made some changes to document
- may need interaction with IHE-HL7 Joint Workgroup (HSI), in relation to using the provenance FHIR resource. Need a PSS work item for HSI with PCC and Patient Care as co-sponsors. HSI will sponsor
- discussion around using PCC-1 Share Content
- will likely need a new transaction that provides more explicit/specific guidance
- Options section need to be implementation agnostic (remove specific references to CDA, PCC TF and FHIR)
Remote Patient Monitoring (RPM)
- Brian led discussion, reviewed actor/transaction diagrams
- discussion resulted in clarity of actor/transaction definitions, and use of grouping
- Clean up of various diagrams
- Clean up of Other dependencies section
Device Clinical Bridge (DCB)
- Alex led discussion, reviewed actors/transactions diagrams
- actors and transactions we reworked based on committee feedback
- next action: Alex to apply changes to DCM document for follow up session
- - updated 2nd use case - clinical to billing use case.
- Clarification of Transaction (multiple back and forth until it is done - multiple activities can occur. Will be a complete business request)
Workflow Discussion
- Keith led discussion, reviewed selection of BPMN as the standard of choice
- Dave Stumpf/Jesse Shiah from AgilePoint discussed reasons for using BPEL and/or XPDL
- next action: for Dave to bring details to next session on market penetration levels for XPDL/BPEL vs BPMN
DAF
- Keith led international discussion
- decision made to not proceed further with international DAF efforts as there really does not seem to be much to do
- Alex/Dragon led IHE USA extension discussion
- DAF US extension is mostly complete
- next steps - develop testing tools
- would like to test at Connectathon 2016 (CAT16)
Tuesday 2025 02 24
Attendees
- Keith Boone
- Alex Lippitt
- George Cole
- Mike Bohl
- Tone Southerland
- Thom Kuhn
- Chris Lindop
- Brian Reinhold
- Dave Stumpf
- Emma Jones